129 related articles for article (PubMed ID: 10772434)
1. Outpatient carboplatin desensitization in a pediatric patient with bilateral optic glioma.
Sims-McCallum RP
Ann Pharmacother; 2000 Apr; 34(4):477-8. PubMed ID: 10772434
[TBL] [Abstract][Full Text] [Related]
2. Carboplatin hypersensitivity and desensitization in an infant.
Montiel Herrera JM; Góngora-Melendez MA; Pineda-Maldonado ML; Medina-Sanson A; Del Rio Chivardi JM; Del Río-Navarro BE; Rosas-Vargas MA
Ther Drug Monit; 2010 Aug; 32(4):525-8. PubMed ID: 20463633
[TBL] [Abstract][Full Text] [Related]
3. [Successful desensitization protocol for patients with hypersensitivity reactions caused by carboplatin].
Nishio S; Koyanagi T; Miyabe K; Kuromatsu H
Gan To Kagaku Ryoho; 2010 Apr; 37(4):731-3. PubMed ID: 20414037
[TBL] [Abstract][Full Text] [Related]
4. Carboplatin hypersensitivity reaction in pediatric patients with low-grade glioma: a Canadian Pediatric Brain Tumor Consortium experience.
Lafay-Cousin L; Sung L; Carret AS; Hukin J; Wilson B; Johnston DL; Zelcer S; Silva M; Odame I; Mpofu C; Strother D; Bouffet E
Cancer; 2008 Feb; 112(4):892-9. PubMed ID: 18098210
[TBL] [Abstract][Full Text] [Related]
5. Carboplatin Hypersensitivity Reactions in Pediatric Low Grade Glioma Are Protocol Specific and Desensitization Shows Poor Efficacy.
Dodgshun AJ; Hansford JR; Cole T; Choo S; Sullivan MJ
Pediatr Blood Cancer; 2016 Jan; 63(1):17-20. PubMed ID: 26207610
[TBL] [Abstract][Full Text] [Related]
6. Carboplatin Rechallenge After Hypersensitivity Reactions in Pediatric Patients With Low-Grade Glioma.
Shah AC; Minturn JE; Li Y; Belasco JB; Phillips PC; Kang TI; Cole KA; Waanders AJ; Pollack R; Didomenico C; Wildes C; Fisher MJ
Pediatr Blood Cancer; 2016 Jan; 63(1):21-6. PubMed ID: 26235452
[TBL] [Abstract][Full Text] [Related]
7. Rapid inpatient/outpatient desensitization for chemotherapy hypersensitivity: standard protocol effective in 57 patients for 255 courses.
Lee CW; Matulonis UA; Castells MC
Gynecol Oncol; 2005 Nov; 99(2):393-9. PubMed ID: 16054201
[TBL] [Abstract][Full Text] [Related]
8. Hypersensitivity reactions and the utility of oral and intravenous desensitization in patients with gynecologic malignancies.
Robinson JB; Singh D; Bodurka-Bevers DC; Wharton JT; Gershenson DM; Wolf JK
Gynecol Oncol; 2001 Sep; 82(3):550-8. PubMed ID: 11520154
[TBL] [Abstract][Full Text] [Related]
9. Development and implementation of a carboplatin desensitization protocol for children with neurofibromatosis, type 1 and hypersensitivity reactions in an outpatient oncology clinic.
Ogle SK; Rose MM; Wildes CT
J Pediatr Oncol Nurs; 2002; 19(4):122-6. PubMed ID: 12203191
[TBL] [Abstract][Full Text] [Related]
10. Successful administration of carboplatin in patients with clinically documented carboplatin hypersensitivity.
Rose PG; Fusco N; Smrekar M; Mossbruger K; Rodriguez M
Gynecol Oncol; 2003 Jun; 89(3):429-33. PubMed ID: 12798707
[TBL] [Abstract][Full Text] [Related]
11. Carboplatin desensitization.
Choi J; Harnett P; Fulcher DA
Ann Allergy Asthma Immunol; 2004 Aug; 93(2):137-41. PubMed ID: 15328672
[TBL] [Abstract][Full Text] [Related]
12. Successful desensitization to carboplatin in patients with systemic hypersensitivity reactions.
Broome CB; Schiff RI; Friedman HS
Med Pediatr Oncol; 1996 Feb; 26(2):105-10. PubMed ID: 8531847
[TBL] [Abstract][Full Text] [Related]
13. Outpatient rapid 4-step desensitization for gynecologic oncology patients with mild to low-risk, moderate hypersensitivity reactions to carboplatin/cisplatin.
Li Q; Cohn D; Waller A; Backes F; Copeland L; Fowler J; Salani R; O'Malley D
Gynecol Oncol; 2014 Oct; 135(1):90-4. PubMed ID: 25110329
[TBL] [Abstract][Full Text] [Related]
14. A case of prolonged carboplatin therapy in a patient with carboplatin hypersensitivity.
McElroy TM; Gruenigen VE; Waggoner SE
Gynecol Oncol; 2003 Nov; 91(2):435-7. PubMed ID: 14599880
[TBL] [Abstract][Full Text] [Related]
15. Weekly vinblastine in pediatric low-grade glioma patients with carboplatin allergic reaction.
Lafay-Cousin L; Holm S; Qaddoumi I; Nicolin G; Bartels U; Tabori U; Huang A; Bouffet E
Cancer; 2005 Jun; 103(12):2636-42. PubMed ID: 15861409
[TBL] [Abstract][Full Text] [Related]
16. Initial experience with a novel desensitization strategy for carboplatin-associated hypersensitivity reactions: carboplatin-hypersensitivity reactions.
Markman M; Hsieh F; Zanotti K; Webster K; Peterson G; Kulp B; Spicel A; Belinson J
J Cancer Res Clin Oncol; 2004 Jan; 130(1):25-8. PubMed ID: 14564516
[TBL] [Abstract][Full Text] [Related]
17. Life-threatening carboplatin hypersensitivity during conditioning for autologous PBSC transplantation: successful rechallenge after desensitization.
Kook H; Kim KM; Choi SH; Choi BS; Kim HJ; Chung SY; Choi SJ; Hwang TJ
Bone Marrow Transplant; 1998 Apr; 21(7):727-9. PubMed ID: 9578315
[TBL] [Abstract][Full Text] [Related]
18. Hypersensitivity reactions to carboplatin in children.
Lazzareschi I; Ruggiero A; Riccardi R; Attinà G; Colosimo C; Lasorella A
J Neurooncol; 2002 May; 58(1):33-7. PubMed ID: 12160138
[TBL] [Abstract][Full Text] [Related]
19. Clinical features and management of carboplatin-related hypersensitivity reactions in pediatric low-grade glioma.
Genc DB; Canpolat C; Berrak SG
Support Care Cancer; 2012 Feb; 20(2):385-93. PubMed ID: 21416159
[TBL] [Abstract][Full Text] [Related]
20. Immediate type hypersensitivity to chemotherapeutic agents in pediatric patients.
Visitsunthorn N; Utsawapreechawong W; Pacharn P; Jirapongsananuruk O; Vichyanond P
Asian Pac J Allergy Immunol; 2009 Dec; 27(4):191-7. PubMed ID: 20232573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]